Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws

Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.